Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
It is provided exclusively for in vitro laboratory research in qualified experimental settings
Mile High Compounds assumes no liability for misuse or off-label application
Food and Drug Administration (FDA) approved pivekimab sunirine-pvzy (Decnupaz ), a CD123-directed antibody and alkylating agent conjugate, for adults with blastic plasmacytoid dendritic cell neoplasm (BPDCN)
Peptide quality depends on purity, identity verification, and consistency, with research-grade material synthesized to high purity above 98%
J Biol Chem 300:107742
pylori Cell Morphology Scanning electron microscopy revealed morphological alterations on the bacterial surface of H
US$ 27.23
US$ 20.49
US$ 20.91
US$ 27.77
US$ 26.48
US$ 27.88
US$ 29.95
